Clinical Trial Update: Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers

View source ↗

Summary

Clinical trial update on reconstituting a human immune system in a patient-derived xenograft model of genitourinary cancers; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Kidney Cancer
• Prostate Cancer

Snippet

Sponsor: Duke University | Conditions: Genito Urinary Cancer, Bladder Cancer | Status: TERMINATED